These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29136469)

  • 1. Novel Linear Lipopeptide Paenipeptins with Potential for Eradicating Biofilms and Sensitizing Gram-Negative Bacteria to Rifampicin and Clarithromycin.
    Moon SH; Zhang X; Zheng G; Meeker DG; Smeltzer MS; Huang E
    J Med Chem; 2017 Dec; 60(23):9630-9640. PubMed ID: 29136469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against Carbapenem-Resistant Pathogens.
    Moon SH; Huang E
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
    Huang E; Yang X; Zhang L; Moon SH; Yousef AE
    FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatically-crosslinked gelatin hydrogels containing paenipeptin and clarithromycin against carbapenem-resistant pathogen in murine skin wound infection.
    Moon SH; Kaufmann Y; Fujiwara R; Huang E
    BMC Microbiol; 2021 Nov; 21(1):326. PubMed ID: 34819026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homo and Hetero-Branched Lipopeptide Dendrimers: Synthesis and Antimicrobial Activity.
    Lamba S; Heruka De Zoysa G; Wang K; Lu J; Swift S; Sarojni V
    Bioorg Chem; 2024 Sep; 150():107567. PubMed ID: 38936047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against
    Moon SH; Kaufmann Y; Huang E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
    Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
    J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibacterial naphthoquinone derivatives targeting resistant strain Gram-negative bacteria in biofilms.
    Novais JS; Moreira CS; Silva ACJA; Loureiro RS; Sá Figueiredo AM; Ferreira VF; Castro HC; da Rocha DR
    Microb Pathog; 2018 May; 118():105-114. PubMed ID: 29550501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
    Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
    Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.
    Russell CC; Stevens A; Pi H; Khazandi M; Ogunniyi AD; Young KA; Baker JR; McCluskey SN; Page SW; Trott DJ; McCluskey A
    ChemMedChem; 2018 Dec; 13(23):2573-2580. PubMed ID: 30318716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Potency of
    Oliva A; Costantini S; De Angelis M; Garzoli S; Božović M; Mascellino MT; Vullo V; Ragno R
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30304862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides.
    De Zoysa GH; Cameron AJ; Hegde VV; Raghothama S; Sarojini V
    J Med Chem; 2015 Jan; 58(2):625-39. PubMed ID: 25495219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.